Date Name Title Filing Type Shares Traded Price Total Held
Feb 14, 2012
Director, President & CEO
Director, President & CEO Form 4 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 250,000 $19.43 517,775
Feb 14, 2012
Director, President & CEO
Director, President & CEO Form 4 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 250,000 -- --
Dec 16, 2011
Director, President & CEO
Director, President & CEO Form 4 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 250,000 $28.01 343,992
Dec 16, 2011
Director, President & CEO
Director, President & CEO Form 4 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 250,000 -- --
Dec 14, 2010
Director, EVP CSO & Pres Regn Res Labs
Director, EVP CSO & Pres Regn Res Labs Form 4/A Grant, award or other acquisition pursuant to Rule 16b-3(d) 250,000 -- 870,375
Dec 17, 2007
Director, Chief Exec Officer & President, Ten Percent Owner
Director, Chief Exec Officer & President, Ten Percent Owner Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 250,000 -- 250,000
Dec 18, 2006
Director, Chief Exec Officer & President, Ten Percent Owner
Director, Chief Exec Officer & President, Ten Percent Owner Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 250,000 -- 250,000
Dec 19, 2005
Director, Chief Exec Officer & President, Ten Percent Owner
Director, Chief Exec Officer & President, Ten Percent Owner Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 250,000 -- 250,000
Feb 23, 2021
Director
Director Form 4 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 248,079 $52.03 487,088
Feb 23, 2021
Director
Director Form 4 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 248,079 -- --

* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.